Skip to main content

How Effective is Atomoxetine in Children and Adolescents?

https://www.thecarlatreport.com/podcast/how-effective-is-atomoxetine-in-children-and-adolescents/

 

Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. With the recent approval of another non-stimulant ADHD medication (viloxazine, brand name Qelbree), this is a good time to revisit atomoxetine. How effective is it? What are some of its pros and cons? This podcast will clarify the position of atomoxetine in our toolbox for treating children and adolescents with ADHD. 

Author
Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

Landmark article on autism care

A new landmark article on autism care was released on December 24, 2024. This article, by Dr. Diane Cullinane and a team including Dr Feder, is the defining foundation for the field of Developmental Relationship Based approaches to autism . Read it free!